These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32282091)

  • 1. Characterization of CaMKIIα holoenzyme stability.
    Torres-Ocampo AP; Özden C; Hommer A; Gardella A; Lapinskas E; Samkutty A; Esposito E; Garman SC; Stratton MM
    Protein Sci; 2020 Jun; 29(6):1524-1534. PubMed ID: 32282091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mechanism for tunable autoinhibition in the structure of a human Ca2+/calmodulin- dependent kinase II holoenzyme.
    Chao LH; Stratton MM; Lee IH; Rosenberg OS; Levitz J; Mandell DJ; Kortemme T; Groves JT; Schulman H; Kuriyan J
    Cell; 2011 Sep; 146(5):732-45. PubMed ID: 21884935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural rearrangement of CaMKIIalpha catalytic domains encodes activation.
    Thaler C; Koushik SV; Puhl HL; Blank PS; Vogel SS
    Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6369-74. PubMed ID: 19339497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the autoinhibited kinase domain of CaMKII and SAXS analysis of the holoenzyme.
    Rosenberg OS; Deindl S; Sung RJ; Nairn AC; Kuriyan J
    Cell; 2005 Dec; 123(5):849-60. PubMed ID: 16325579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CaMKII holoenzyme structure in activation-competent conformations.
    Myers JB; Zaegel V; Coultrap SJ; Miller AP; Bayer KU; Reichow SL
    Nat Commun; 2017 Jun; 8():15742. PubMed ID: 28589927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation-triggered subunit exchange between CaMKII holoenzymes facilitates the spread of kinase activity.
    Stratton M; Lee IH; Bhattacharyya M; Christensen SM; Chao LH; Schulman H; Groves JT; Kuriyan J
    Elife; 2014 Jan; 3():e01610. PubMed ID: 24473075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ca2+/CaM dependent protein kinase II (CaMKII)α and CaMKIIβ hub domains adopt distinct oligomeric states and stabilities.
    Özden C; MacManus S; Adafia R; Samkutty A; Torres-Ocampo AP; Garman SC; Stratton MM
    Protein Sci; 2024 Apr; 33(4):e4960. PubMed ID: 38501502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in assembly stoichiometry in non-metazoan homologs of the hub domain of Ca
    McSpadden ED; Xia Z; Chi CC; Susa AC; Shah NH; Gee CL; Williams ER; Kuriyan J
    Protein Sci; 2019 Jun; 28(6):1071-1082. PubMed ID: 30942928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GHB analogs confer neuroprotection through specific interaction with the CaMKIIα hub domain.
    Leurs U; Klein AB; McSpadden ED; Griem-Krey N; Solbak SMØ; Houlton J; Villumsen IS; Vogensen SB; Hamborg L; Gauger SJ; Palmelund LB; Larsen ASG; Shehata MA; Kelstrup CD; Olsen JV; Bach A; Burnie RO; Kerr DS; Gowing EK; Teurlings SMW; Chi CC; Gee CL; Frølund B; Kornum BR; van Woerden GM; Clausen RP; Kuriyan J; Clarkson AN; Wellendorph P
    Proc Natl Acad Sci U S A; 2021 Aug; 118(31):. PubMed ID: 34330837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hub stability in the calcium calmodulin-dependent protein kinase II.
    Chien CT; Puhl H; Vogel SS; Molloy JE; Chiu W; Khan S
    Commun Biol; 2024 Jun; 7(1):766. PubMed ID: 38918547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the CaMKIIα and β splice-variant distribution among brain regions reveals isoform-specific differences in holoenzyme formation.
    Cook SG; Bourke AM; O'Leary H; Zaegel V; Lasda E; Mize-Berge J; Quillinan N; Tucker CL; Coultrap SJ; Herson PS; Bayer KU
    Sci Rep; 2018 Apr; 8(1):5448. PubMed ID: 29615706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligomerization states of the association domain and the holoenyzme of Ca2+/CaM kinase II.
    Rosenberg OS; Deindl S; Comolli LR; Hoelz A; Downing KH; Nairn AC; Kuriyan J
    FEBS J; 2006 Feb; 273(4):682-94. PubMed ID: 16441656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covert Changes in CaMKII Holoenzyme Structure Identified for Activation and Subsequent Interactions.
    Nguyen TA; Sarkar P; Veetil JV; Davis KA; Puhl HL; Vogel SS
    Biophys J; 2015 May; 108(9):2158-70. PubMed ID: 25954874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural studies on the regulation of Ca2+/calmodulin dependent protein kinase II.
    Stratton MM; Chao LH; Schulman H; Kuriyan J
    Curr Opin Struct Biol; 2013 Apr; 23(2):292-301. PubMed ID: 23632248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CaMKII activation and dynamics are independent of the holoenzyme structure: an infinite subunit holoenzyme approximation.
    Michalski PJ; Loew LM
    Phys Biol; 2012 Jun; 9(3):036010. PubMed ID: 22683827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-time single-molecule imaging of CaMKII-calmodulin interactions.
    Khan S; Molloy JE; Puhl H; Schulman H; Vogel SS
    Biophys J; 2024 Apr; 123(7):824-838. PubMed ID: 38414237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of the CaMKIIdelta/calmodulin complex reveals the molecular mechanism of CaMKII kinase activation.
    Rellos P; Pike AC; Niesen FH; Salah E; Lee WH; von Delft F; Knapp S
    PLoS Biol; 2010 Jul; 8(7):e1000426. PubMed ID: 20668654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conserved and divergent features of neuronal CaMKII holoenzyme structure, function, and high-order assembly.
    Buonarati OR; Miller AP; Coultrap SJ; Bayer KU; Reichow SL
    Cell Rep; 2021 Dec; 37(13):110168. PubMed ID: 34965414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deciphering CaMKII Multimerization Using Fluorescence Correlation Spectroscopy and Homo-FRET Analysis.
    Sarkar P; Davis KA; Puhl HL; Veetil JV; Nguyen TA; Vogel SS
    Biophys J; 2017 Mar; 112(6):1270-1281. PubMed ID: 28355553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CaMKIIα hub ligand Ph-HTBA promotes neuroprotection after focal ischemic stroke by a distinct molecular interaction.
    Griem-Krey N; Gauger SJ; Gowing EK; Thiesen L; Frølund B; Clarkson AN; Wellendorph P
    Biomed Pharmacother; 2022 Dec; 156():113895. PubMed ID: 36274464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.